12 Nov 2021
// K. LaHucik FIERCEBIOTECH
https://www.fiercebiotech.com/biotech/acrivon-therapeutics-secures-100m-to-give-eli-lilly-cancer-drug-another-try-fund-2-solid
27 Oct 2021
// Angus Liu FIERCEBIOTECH
https://www.fiercebiotech.com/research/genetic-signature-behind-drugs-astrazeneca-bayer-eli-lilly-boost-cancer-immunotherapy
01 May 2019
// Eric Sagonowsky FIERCE PHARMA
https://www.fiercepharma.com/pharma/lilly-s-light-sales-for-trulicity-taltz-prompt-analyst-questions
30 Apr 2019
// John Carroll ENDPTS
https://endpts.com/suffering-a-series-of-setbacks-eli-lillys-oncology-group-quietly-executes-2-of-its-top-mid-stage-drugs/
30 Apr 2019
// Amirah Al Idrus FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/lilly-dumps-phase-2-cancer-drugs-survived-previous-cull